Interruption of breast feeding related to drugs consumption
Keywords:
breast feeding, weaning, PharmacistAbstract
Introduction: WHO recommends that during the first six months of life, infants should be fed exclusively with breast milk. From that moment, they should receive adequate and safe complementary foods, without abandoning breastfeeding at least until two years of age. Pharmacological treatment is one ofthe reasons for abandoning breastfeeding despite the fact that most current medications are compatible with breastfeeding.
Objective: To determine the causes of the interruption of breastfeeding in women participants of two national virtual platforms.
Method: Observational, descriptive study using a virtual survey of 33 women who have suspended breastfeeding from April 2015 to April 2017, participants of two virtual breastfeeding and maternitysupport platforms in Paraguay. Sampling not probabilistic for convenience.
Results: The average age of 28 ± 4.2 years, mostly university, residents in the Central department. 30.3% of weaning was detected before 6 months, and only 9.0% reached 24 months of breastfeeding recommended by WHO. The causes of the most frequent interruption of breastfeeding were medication (36.4%), followed by a feeling of lack of milk (27.3%) and that thechild was left hungry (18.2%).
Conclusions: The medication represented the major cause of involuntary weaning, being compatible with breastfeeding drugs inmore than half of the cases reported. The pharmacist, a professional with greater knowledge of information sources on medications, could have contributed in these cases to the preservation of breastfeeding
Downloads
References
Delgado-Becerra A, Arroyo-Cabrales LM, Díaz-García MA, Quezada-Salazar CA. Prevalencia y causas de abandono de lactancia materna en el alojamiento conjunto de una institución de tercer nivel de atención. Bol Med Hosp Infant Mex. 2006; 63(1): 31-39.
Organización Mundial de la Salud. Estrategia mundial para la alimentación del lactante y del niño pequeño. 2003. Dis¬ponible en: https://www.who.int/nutrition/publications/gs_infant_feeding_text_spa.pdf. OMS .Ginebra.
OPS-Paraguay. Leche materna desde la primera hora de vida. [fecha de acceso 2019 Mayo 07] Disponible en: https://www.paho.org/par/index.php?option=com_content&view=article&id=2009:leche-materna-desde-la-primera-hora-de-vida&Itemid=255
Ministerio de Salud Pública y Bienestar Social. Niveles de lactancia materna deben incrementarse. [revista en la Internet] 2016; [citado 2016 Noviembre 21]. Disponible en: http://www.mspbs.gov.py/niveles- de-lactancia-materna-deben- aumentar
Locio LM, Hermosilla M. Razones de abandono de lactancia materna en madres con hijos menores de 2 años. Mem Inst Investig Cienc Salud. 2017;15(2):73–78.
Pezzani VM, Soto HP, Pineda LR, Pinilla RE, Ruiz AI. Cumplimiento de la lactancia materna. Una perspectiva desde las oficinas de farmacia. Rev chil pediatr. [revista en la Internet]. 1998; 69(3): 99-103.
Fragoso VMS, Silva ED, Mota JM. Breastfeeding women under medication treatment in the public health network. Rev Bras Promoç Saúde. 2014; 27(2):283-290.
Mota LS, Chaves EMC, Barbosa RCM, Amaral JF, Farias LM, Almeida PC. Use of drugs during lactation by users of a basic health unit. Rev Rene. 2013; 14(1):139-147.
Lopes Chaves AF, Marques Dias AH, Almeida Dias IK, Silva Martins JK, Silveira Rocha R, Batista Oriá MO. Consumo de medicamentos durante a amamentação e avaliação do risco ao lactente. Revista da Rede de Enfermagem do Nordeste [revista en la Internet]. 2017 [fecha de acceso 2019 Octubre 07]; 18(3): 390-395. Doi: 10.15253/2175-6783.2017000300015
Vauzelle C, Beghin D, Elefant E. Pediatría: Medicamentos y lactancia materna. Tratado de Medicina [Internet]. 2014 [citado 2019 Mayo 4];18(2):1–12. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1636541014675279
Hale TW, Rowe HE. Medications and Mothers’ Milk 2017 [Internet]. Vol. Seventeenth edition. New York, NY: Springer Publishing Company; 2017 [citado 2018 Octubre 4]. Disponible en: http://lghttp.48653.nexcesscdn.net/80223CF/springer-sta-tic/media/samplechapters/9780826128584/9780826128584_chapter.pdf
E-lactancia. ¿Es compatible con la lactancia? [Internet].[citado 2019 Enero 4] Disponible en: http://www.e-lactancia.org/.
Paricio TJM, Lasarte VJJ. Lactancia y Medicamentos: Una compatibilidad casi siempre posible. Guía rápida para profesionales. Editorial: Comité de lactancia materna de la Asociación Española de Pediatría. 2018 [Internet]. [citado 2018 Octubre 23] Disponible en: https://www.aeped.es/comite-lactancia-materna/documentos/guia-rapida-compatibilidad-entre-medicamentos-y-lactancia-matern.
Bertolín GJM, Company ES. Use of antipsychotics during pregnancy and breastfeeding. Rev Psiquiatr y Salud Ment. 2009;2(3):138–145.
Pablos A, Pérez-Suárez B, Ferrari JM, Guerra A, Herreros de Tejada A, Ortiz-Romero P. Administración de fármacos utilizados en dermatología durante el embarazo y la lactancia (I). Actas Dermo-sifiliográficas .2003; 94(7):427–449.
Moranta Ribas F. Consulta farmacéutica por somnolencia en un lactante. Farmacéuticos Comunitarios. 2016;8(4):42–4.
Salar L, Sola N, Cámara R, Cosín A, Dago A Gutiérrez P. Conocimiento del paciente sobre su medicación: relación entre el conocimiento y la percepción de efectividad y seguridad del tratamiento. Farmacéuticos Comunitarios. 2016;8(1):24–31.
García Cardona AA, Castaño Castrillón JJ, Vallejo Corrales S, Vargas Meneses JD. Razones de abandono de la lactancia materna en madres de niños de jardines infantiles, Manizales, Colombia, 2015: Estudio descriptivo. Archivos de medicina. 2017;17(2):369-378.
Estrada RJ, Amargós RJ, Reyes DB, Guevara BA. Intervención educativa sobre lactancia materna. Archivo Médico de Camagüey .2010 ;14(2).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Debora Viviana Acosta, Gladys Lugo Rodriguez, María Gloria Domenech, Zully Vera de Molinas, Gladys Maidana de Larrosa, Lourdes Samaniego Silva
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
